Whitehawk Therapeutics (WHWK) Share-based Compensation Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -34.72% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.80% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 10.78% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.55% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.65% |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - | -7.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.15% |
| Dec 31, 2025 | -5.94% |
| Sep 30, 2025 | -0.47% |
| Jun 30, 2025 | 11.37% |
| Mar 31, 2025 | -1.93% |
| Dec 31, 2024 | 10.26% |
| Sep 30, 2024 | 58.02% |
| Jun 30, 2024 | 317.54% |
| Mar 31, 2024 | 363.69% |
| Dec 31, 2023 | 330.47% |
| Sep 30, 2023 | 347.60% |
| Jun 30, 2023 | 114.76% |
| Mar 31, 2023 | 103.01% |
| Dec 31, 2022 | 78.10% |
| Sep 30, 2022 | 62.21% |
| Jun 30, 2022 | 54.62% |
| Mar 31, 2022 | 42.02% |
| Dec 31, 2021 | 27.45% |
| Sep 30, 2021 | -7.03% |
| Jun 30, 2021 | -64.58% |
| Mar 31, 2021 | -67.81% |
| Dec 31, 2020 | -46.53% |
| Sep 30, 2020 | -35.61% |
| Jun 30, 2020 | 40.35% |
| Mar 31, 2020 | 28.21% |
| Dec 31, 2019 | -100.39% |
| Sep 30, 2019 | 78.54% |
| Jun 30, 2019 | 71.65% |
| Mar 31, 2019 | 70.60% |